Patient Square Capital

Patient Square Capital is pleased to announce a strategic investment in CorroHealth, a leading provider of revenue cycle management (RCM) solutions to health systems and health plans. This partnership will expand CorroHealth’s differentiated footprint and bring innovative tech-enabled solutions to provider and payer customers. We look forward to partnering with Corro’s management team and investors to build upon a strong track record of organic and inorganic growth. Read more about this partnership: https://lnkd.in/eKKAAMvh   #CorroHealth #healthcare #privateequity #partnership

Patient Square Capital is excited to announce that James (Jim) Mazzo, one of the ophthalmic industry’s most venerated business leaders, has joined as an Industry Advisor. Mr. Mazzo has over 40 years of proven experience building and running world-class organizations, including running Allergan’s North American and European eye care organizations, Advanced Medical Optics (AMO), Abbott’s global ophthalmology business and Carl Zeiss Meditec’s ophthalmic devices business. Mr. Mazzo's expertise and insights will further strengthen our sourcing, diligence, and governance capabilities. Read more about Mr. Mazzo and the valuable expertise he brings to the Patient Square Capital team: https://lnkd.in/egj3nkNi   #healthcare #privateequity

Patient Square Capital is honored to be recognized by GrowthCap as a Top Private Equity Firm of 2024. The founding vision of Patient Square Capital is that a market as large, complex, and impactful as health care requires scale and specialization. Our name is derived both from our patient approach to investing signifying the years of hard work that lead to successful investments and the centricity of patients to everything we do. This recognition underscores Patient Square Capital's deep industry expertise, proprietary in-house resources, and differentiated network of relationships, which enable us to partner with companies that are expected to drive greater innovation and efficiency in health care. Read more here: https://lnkd.in/eRjH5Wnj #privateequity #healthcare   This award is the opinion of the party conferring the award and not of Patient Square Capital. Patient Square Capital submitted a nomination, and once selected, paid a publishing and copyright fee to promote this award. There can be no assurance that other providers or surveys would reach the same conclusion as the party conferring the award referenced herein.

Patient Square Capital is delighted to share that portfolio company Apollo Therapeutics has entered into a new drug discovery and development collaboration with the University of Oxford. The collaboration will see teams from Apollo Therapeutics and the University of Oxford working together to identify and assess the potential of novel validated therapeutic targets, bringing Apollo Therapeutics' in-house expertise and resources to Oxford’s world class researchers and delivering faster routes to market for new medicines. Read the full press release here: https://lnkd.in/eH95J4c5 #ApolloTherapeutics #UKscience #Collaboration #UniversityofOxford

We are pleased to announce that Tom Stanton has joined Patient Square Capital as Managing Director and Head of Private Wealth. With nearly three decades of experience developing sophisticated solutions across the private wealth management sector, Tom will play a pivotal role in enhancing our capabilities in this market. #healthcare #privateequity 

Managing Partner Jim Momtazee will deliver a keynote at SuperReturn International in Berlin for the fourth consecutive year. If you are attending the conference, we would be thrilled for you to join “The Process is the Product: What Matters Most is Rarely Discussed” on Wednesday, June 5th. See additional details here: https://lnkd.in/gZPJz5z

Our Chief Compliance Officer Carolyn Drayer-Greenwalt shares how her experience at the U.S. Securities and Exchange Commission inspired her to join Patient Square Capital. She highlights why trust and internal support are important to building a strong compliance program while adapting to the evolving needs of a shifting regulatory landscape. Read the full article from her interview with Modern Counsel here: https://lnkd.in/gbTkJEhW #law #privateequity 

We are pleased to announce that Bhavna Vashisht Katkar has joined Patient Square as Head of Human Capital and Corporate Affairs. Bhavna brings over two decades of experience and leadership across firm operations, human capital, corporate affairs and capital formation. The addition of Bhavna reflects Patient Square Capital’s commitment to developing our team and enhancing our communication with our most important partners as we seek to invest in outstanding health care companies and to serve patients. #healthcare #privateequity

We are pleased to announce that Bhavna Vashisht Katkar has joined Patient Square as Head of Human Capital and Corporate Affairs. Bhavna brings over two decades of experience and leadership across firm operations, human capital, corporate affairs and capital formation. The addition of Bhavna reflects Patient Square Capital’s commitment to developing our team and enhancing our communication with our most important partners as we seek to invest in outstanding health care companies and to serve patients. #healthcare #privateequity

Ken Michalzuk has joined Patient Square as a Managing Director on our Transformation and Growth Team. Ken brings decades of experience leading transformation and driving value at health care companies alongside management teams. His deep experience in the health care industry will be a tremendous asset to our portfolio companies and the patients they serve. #healthcare #privateequity